Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

Clinical trial NCT06274801 · RECRUITING

Trial details

NCT number: NCT06274801
Sponsor: Gossamer Bio USA, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2024-09-03
Primary completion: 2026-12-01
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.